You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Phillip Gold

Executive Director-Clinical Research Center at McGill University Health Center
Overview
Relationships
Paths
Education
Memberships
Career History
Boards & Committees

Phillip Gold

Executive Director-Clinical Research Center at McGill University Health Center

Overview

Age
76 (Born 1941)
Notable Companies
McGill University Health Center
Board Seats
9
Number of Relationships
This person is connected to 591 people.

Relationships See Details


Former President & Chief Executive Officer at Genome Canada

Principal & Vice Chancellor at McGill University

National Executive Director at Weizmann Canada

Member, Montreal Scientific Advisory Board at Weizmann Canada

Member, Scientific Advisory Board at Effector Therapeutics, Inc.

Director at Aurelium BioPharma, Inc.

Director at Aurelium BioPharma, Inc.

Managing Member at Bamburgh Marrsh LLC

Executive Chairman at Biosensia Ltd.

Chief Executive Officer & Founder at Ellipsis Neurotherapeutics, Inc.
See 581 more listings with RelSci Professional.

Paths to Phillip Gold

Phillip Gold
You
Connections via Relationship Science
Phillip Gold
Sync your contacts to see how you can connect with Phillip Gold.

Educational Background

 
McGill University is a public research university located in Montreal, Quebec, Canada. Founded in 1821 during the British colonial era, the university bears the name of James McGill, a prominent Montreal merchant from Glasgow, Scotland and alumnus of Glasgow University, whose bequest formed the beginning of the university.

Memberships

Member
Current
PUBLICATION OF A RESEARCH JOURNAL AND DISSEMINATION OF RELATED INFORMATION.
Member
Current
ADVANCEMENT OF SCIENCE AND MEDICINE.
Member
Current

Career History

Executive Director-Clinical Research Center
1968 - Current
McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada.
Professor-Physiology & Oncology
Current
McGill University is a public research university located in Montreal, Quebec, Canada. Founded in 1821 during the British colonial era, the university bears the name of James McGill, a prominent Montreal merchant from Glasgow, Scotland and alumnus of Glasgow University, whose bequest formed the beginning of the university.
Professional
1980 - Prior
Professional
Prior

Boards & Committees

Corporate Boards ▾
Chairman
Current
Aurelium BioPharma Inc., develops therapeutics and diagnostics for the treatment of drug-resistant cancers. The company has developed several diagnostic tests for the detection of breast, ovarian as well as drug-resistant cancers. The firm has a strong drugable pipeline of novel targets and complimentary diagnostic products that are utilized in its strategic collaborations and out-licensing efforts. The company was founded in May 1998 and is headquartered in Laval, Canada.
Director
2007 - Prior
Bradmer Pharmaceuticals, Inc. engages in the development and commercialization of cancer therapies. The company was founded on February 10, 2006 and is headquartered in Toronto, Canada.
Director
2003 - 2005
The fundamental investment objective of BioCapital is to provide investors superior capital appreciation by investing in equity securities of public companies with high growth potential in biotechnology industries. They seek to achieve this fundamental objective by investing in a diversified portfolio of public companies primarily in the following sectors of the biotechnology industry: therapeutics in the fields of cancer, cardiology, infectious diseases, immune system and central nervous system. The firm also invests in companies developing platform technologies in the fields on genomics and proteomics, drug delivery, theranostics, nanotechnology and monoclonal antibody.
Independent Director
2001 - 2012
BioCurex, Inc. engages in the business of developing, producing, marketing and licensing products based on patented and proprietary technology in the area of cancer diagnostics. It focuses on developing and commercializing products for the early detection, diagnosis, and monitoring the recurrence of cancer. It has developed a blood test that can detect the presence of cancer in humans and animals using a new cancer marker named RECAF. RECAF is a molecule found on most cancer cells, including breast, colon, prostate and lung cancers, but not on normal cells and it also can be used in blood tests to determine if a patient has cancer. The company was founded by Ricardo Moro-Vidal on December 8, 1997 and is headquartered in Richmond, Canada.
Director
1978 - 1980
Director
Prior
The Group's principal activity is to develop, manufacture and sell pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). The Group owns and operates its research, development and manufacturing facilities in China through its subsidiaries. Revenues are generated mainly in China, Europe and South East Asia.
Member, Board of Directors
Prior
Non-Profit Boards ▾
Member, Montreal Scientific Advisory Board
Current
Board Member
Prior
The Burroughs Wellcome Fund is an independent private foundation dedicated to advancing the biomedical sciences by supporting research and other scientific and educational activities. BWF’s financial support is channeled primarily through competitive peer-reviewed award programs. BWF makes grants primarily to degree-granting institutions on behalf of individual researchers, who must be nominated by their institutions. To complement these competitive award programs, BWF also makes grants to nonprofit organizations conducting activities intended to improve the general environment for science.

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial ➤
Still not convinced? Check out our full listing of features here.